Signals Magazine
www.rDNA.com
www.RecapRx.com
www.RecapIP.com
Allicense

What's New
 
07/31/2010
New Data

Recap's biotech databases are always evolving. Every day our consultants track alliances, gather contracts, compose and update analyses, and record financing rounds. Check the lists below for some recent additions to our site. A subscription to either Recap.com or rDNA.com is necessary to access the documents.


Access: Recap.com and rDNA.com
Records: 33,433 Alliance Summaries & 34,853 Press Releases

Here we list the most recent biotech corporate alliances added to our comprehensive database. We create an Alliance Summary record when a deal is first announced, usually in a Press Release. The record is indexed by several categories such as disease, technology, and development stage, and the record may be linked to press releases. (Sample)

addedpartiestypesubject
17/30/10Laboratorios INIBSA / Stellar PharmaceuticalsDi, LUracyst interstitial cystitis/painful bladder syndrome in Spain
27/30/10UCB / Actient PharmaceuticalsL, OEdex, Theo-24, Semprex-D Capsules, Levatol, Robaxin and Dilatrate-SR in US
37/30/10Publicis / Somaxon PharmaceuticalsMktSilenor (doxepin) for the treatment of insomnia in US
47/30/10Global Health Ventures / Carter PharmaceuticalSPrototype manufacturing of sublingual anti-anxiety drug
57/30/10Gladstone Institutes / Lundbeck A/SCol, RCollaboration to identify therapeutic candidates for neurological diseases
67/30/10EXACT Sciences / OncoMethylome SciencesLDNA methylation biomarkers for use in stool-based detection of colorectal cancer
77/30/10Dievini Hopp BioTech / WilexAcqMandatory takeover bid by dievini Hopp BioTech holding
87/30/10Cegedim / IMS HealthAstSwiss CRM And Direct Marketing Business from IMS Health
97/30/10Astellas Pharma / MediGeneLEligard leuprolide acetate for the treatment of hormone-dependent prostate cancer in Europe
107/29/10IBM / RocheCol, DNanopore-based DNA sequencing technology
117/29/10NEXUS Biosystems / REMP AGAcqAcq. of REMP Sample Management business subsidiary
127/29/10Newcastle University, UK Stem Cell Bank / Orla Protein TechnologiesCol, RStudy of mammalian cells cultured in the lab
137/29/10University of Bergen / OvaGene OncologyLGene-based technologies to develop endometrial cancer assays
147/29/10Sristi Biosciences / Lifeline Cell TechnologyDiDistribution of Lifeline brand of human cell culture products in India
157/29/10Siena Biotech / AptuitCol, D, EDevelopment pipeline support & acq. of minority stake in Aptuit's Italian operations
167/29/10PharmaChem / Forbes Medi-TechAcqProposal to acquire Forbes Medi-Tech for cash
177/29/10Meridian Bioscience / BiolineAcqAcq. of Bioline for cash
187/29/10Medinnova / OvaGene OncologyLTechnology to detect chemoradiation resistance in cervical cancer patients
197/29/10Leukemia & Lymphoma Society / Shape PharmaceuticalsCol, DSHP-141topical treatment for cutaneous T-Cell lymphoma
207/29/10Jade Pharmaceutical / Shanxi Baotai PharmaceuticalAcq, LoIAcq. of Shanxi Baotai Pharmaceutical


Access: rDNA.com
Records: 2,026 Contract Analyses

Based on actual alliance contracts, a Contract Analysis offers a detailed view of the responsibilities of the parties involved in an alliance. Our consultants continually update Contract Analyses as additional data becomes available. (Sample)

modpartiesdatesubject
17/28/10Bayer / Onyx Pharmaceuticals4/1994Nexavar (oral raf kinase inhibitor) for renal cell carcinoma
27/22/10GlaxoSmithKline / Amgen7/2009Denosumab for postmenopausal osteoporosis & oncology in certain markets
37/15/10Solvay / ArQule11/1995Combinatorial screening
47/14/10DuPont Pharmaceuticals / KOS Pharmaceuticals5/2000Advicor for lipid disorders in NA
57/9/10Wyeth-Ayerst, Wyeth / Immunex9/1997Enbrel (etanercept - TNFR) co-promotion in NA
66/9/10Merck / Alnylam Pharmaceuticals6/2004VEGF RNAi for ocular diseases
76/1/10Fujisawa / Centocor8/1996ReoPro (abciximab) for stroke and cardio in Japan
85/30/10Lilly / COR Therapeutics, Millennium5/1991Platelet aggregation inhibitors
95/28/10XOMA / Incyte7/1998BPI human host-defense protein portfolio
105/25/10Pfizer / Medivation8/2008Dimebon for Treatment of Alzheimer's and Huntington's Diseases
115/18/10AstraZeneca / Abraxis BioScience4/2006Diprivan anesthetic and analgesic products in US
125/12/10Menarini / CV Therapeutics9/2008Ranexa in Europe, Central and South America
134/27/10Astellas Pharma / Medivation10/2009MDV3100 for prostate cancer
144/27/10Novartis / Incyte11/2009INCB18424 JAK inhibitor ex-US & INCB28060 cMET inhibitor worldwide
154/27/10UC Los Angeles / Medivation8/2005Prostate cancer compound
164/27/10Biogen Idec / Acorda Therapeutics7/2009Ampyra (fampridine-SR) for Multiple Sclerosis ex-US
174/27/10AstraZeneca / Nektar Therapeutics9/2009NKTR-118 for opioid-induced constipation & NKTR-119 (combination of NKTR-118 and an opioidanalgensic) for pain
184/27/10AstraZeneca / Targacept12/2009TC-5214 for treatment of major depressive disorder
194/26/10Takeda / Amylin10/2009Pramlintide/metreleptin and davalintide compounds for obesity
204/26/10Millennium / Seattle Genetics12/2009Brentuximab Vedotin (SGN-35) for Lymphoma ex. US & Canada



Latest Filed Contracts
Access: rDNA.com
Records: 25,680 Contracts

Each quarter, Recap Analysts look through every SEC filing from every biotech and pharmaceutical company in search of alliance contracts. Our earliest contracts date back to the 1970's and many of our contracts are unavailable from any other source. (Sample)

modpartiesdatetypesubject
17/29/10LabCorp / EXACT Sciences6/2002LScreening test for colorectal cancer
27/29/10EXACT Sciences / Apogent Technologies11/2002LAcrydite chemistry technology
37/29/10LabCorp / EXACT Sciences3/2008Screening test for colorectal cancer
47/29/10Johns Hopkins / EXACT Sciences3/2003Ldigital-PCR technology
57/29/10Genzyme / EXACT Sciences1/2009Ast, LReproductive and Prenatal Health Assets & Equity Investment
67/29/10Genzyme / EXACT Sciences1/2009SubReproductive and Prenatal Health Assets & Equity Investment
77/29/10Genzyme / EXACT Sciences1/2009LReproductive and Prenatal Health Assets & Equity Investment
87/29/10Genzyme / EXACT Sciences1/2009EReproductive and Prenatal Health Assets & Equity Investment
97/29/10LabCorp / EXACT Sciences1/2004Screening test for colorectal cancer
107/29/10Beckman Coulter / EXACT Sciences7/2003SubFlourescence polarization patents in NA
117/29/10Johns Hopkins / EXACT Sciences12/2008Ldigital-PCR technology
127/29/10Mayo Clinic / EXACT Sciences6/2009WNon-invasive stool-based DNA screening for colorectal cancer
137/29/10Mayo Clinic / EXACT Sciences6/2009WNon-invasive stool-based DNA screening for colorectal cancer
147/29/10Mayo Clinic / EXACT Sciences6/2009LNon-invasive stool-based DNA screening for colorectal cancer
157/29/10EXACT Sciences / Third Wave Technologies10/2009LInvader detection chemistry for colorectal cancer screening
167/28/10DSM Biologics / Martek Biosciences5/2008Supply of nutritional oils (ARA)
177/28/10Wyeth / Martek Biosciences11/2007SOmega-3 and Omega-6 for infant formula
187/28/10DSM Biologics / Martek Biosciences7/2009Supply of nutritional oils (ARA)
197/28/10Martek Biosciences / Amerifit Brands1/2010AcqAcq. of Amerifit Brands for cash
207/28/10Abbott / Centocor3/1984L, SCA 19-9 & CA 125 Ab for cancer diagnosis



Latest Valuation Histories
Access: Full Valuation on rDNA.com, Graphs only on Recap.com
Records: 722 Valuation Histories

Recap Analysts use IPO and SPO data to create a detailed Valuation History for a company. Data recorded for each transaction includes the share price, the number of shares purchased, and the buyer. (Sample)

modcompany
19/25/09Allos Therapeutics
29/25/09Cephalon
39/25/09Dendreon
49/25/09Dyax
59/22/09GenVec
69/22/09Unigene Labs
79/16/09Antigenics
89/16/09Avanir Pharmaceuticals
99/16/09BioTime
109/16/09Cel-Sci
119/16/09Cerus
129/16/09Cortex Pharmaceuticals
139/16/09Cytokinetics
149/16/09Dyax
159/16/09Emisphere Technologies
169/16/09EXACT Sciences
179/16/09Human Genome Sciences
189/16/09ImmunoGen
199/16/09Inspire Pharmaceuticals
209/16/09MannKind


The Analysts' Notebook is prepared by Deloitte Recap LLC’s analysts and consultants using Recap.com and rDNA.com data. For over 15 years Recap Consulting has provided clients with expert advice and in-depth analysis in the areas of alliance structuring and deal valuation.




Copyright © 2010 Deloitte Recap LLC | Privacy Policy | Contact